Delivery Order 36F79724D0026-36C24925F0111
Award Date
1/31/25
Potential Completion Date
6/30/25
Potential Value
$15K
Federal Agency
Veterans Integrated Service Network 9
Awardee
Immunocore Commercial LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of KIMMTRAK (tebentafusp-tebn), a 100MCG/0.5ML injectable pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Immunocore Commercial LLC, a foreign-owned, for-profit manufacturer of goods, through a Total Small Business set-aside. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $14,447.83 and an ultimate completion date of June 30, 2025. Immunocore Commercial LLC holds two...
This federal contract award is for the delivery of KIMMTRAK (tebentafusp-tebn) 100MCG/0.5ML vials, an injectable pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The prime contractor, Immunocore Commercial LLC, is a foreign-owned, for-profit manufacturer of goods registered in the System for Award Management (SAM.gov). The contract, a firm fixed-price delivery order with a ceiling value of $86,686.98, was awarded on October 11, 2024, with an ultimate completion date of...
This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Immunocore Commercial LLC, a foreign-owned for-profit manufacturer of pharmaceutical goods. The contract, valued at $29,452.70, is for the delivery of KIMMTRAK (tebentafusp-tebn), a specialized 100MCG/0.5ML injectable hematology-related pharmaceutical product. The contract is part of a larger Federal Supply Schedule (FSS) Indefinite Delivery Vehicle (IDV) with a $225,000 ceiling value,...
This federal contract award is for the pharmaceutical product Kymriah (tisagenlecleucel), a chimeric antigen receptor T-cell (CAR-T) therapy, provided by the prime contractor Novartis Pharmaceuticals Corporation. The contract has a ceiling value of $283,555.92 and is a Blanket Purchase Agreement (BPA) call under Novartis' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract was awarded by the Department of Veterans Affairs (VA) and is intended to support...
This federal contract award to Novartis Pharmaceuticals Corporation, doing business as NPS, is for the delivery of Kymriah, a specialized cell therapy cancer treatment, to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is issued as a delivery order against Novartis' existing Federal Supply Schedule (FSS) 61-IB contract for pharmaceuticals and drugs, which has a potential value of $5.4 billion and runs through August 2025. The specific delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,155.38 firm fixed-price delivery order is for the supply of 420 mg KANJINTI vials, a specialty cancer medication. The award is not associated with a set-aside program. The contract has an ultimate completion date of July 18, 2024 and is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer, to provide the chimeric antigen receptor T-cell therapy drug Kymriah. The order, valued at $283,567.92, was placed against Novartis' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) and has a firm fixed price. The order supports the VA's medical programs and does not have a...
The U.S. Department of Veterans Affairs (VA) awarded a $27,913.44 firm-fixed price delivery order contract to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, to provide emergency pharmaceutical orders. The contract is a delivery order under Takeda's General Services Administration (GSA) Multiple Award Schedule contract for Pharmaceuticals and Drugs. The contract supports the VA's Veterans Health Administration in delivering specialty...
This federal contract award, valued at $1,588,047.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 A vaccine, a critical product for military immunization programs. The delivery order contract is firm-fixed-price with a period of performance through April 30, 2024. While the original solicitation is not provided, this award is...
This federal contract award, with ID SPE2DX15D3022|SPE2DX24FTXPP, is for the delivery of TENIVAC SYRINGE 0.5ML medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical and medical products to the U.S. federal government, including the military. The prime contractor for this award is Amerisourcebergen Drug Corp, a large pharmaceutical distributor, through its Corporate Office Division. The contract is a Firm Fixed...